Zyvex Pharmaceuticals Ligandrol LGD-4033 10 mg Research Pack
Out of stock
Oral · 20 mg/tab · 100 tabs
Zyvex Pharmaceuticals Cardarine is GW-501516, a PPAR-delta agonist shelved with the receptor modulators but neither a SARM nor a steroid. The checked file records no established half-life, and sulfone metabolites stay detectable in urine for up to forty days after a single dose.
GMP-manufactured, HPLC-verified, COA on file. Cardarine for sale with international shipping.
Zyvex Pharmaceuticals Cardarine is GW-501516 at 20 mg per tablet, supplied as laboratory research material. The fact sheet is blunt about what it is: a PPAR-delta agonist and metabolic modulator, not a SARM and not a steroid, even though it shares a shelf with the receptor modulators. Buy cardarine here as a reference compound if that distinction and the safety record below are understood, because the history of this molecule is the most important thing on the page.
Development of GW-501516 was discontinued in 2007 after carcinogenicity appeared in rodent studies at 3 mg per kg per day, and the compound was added to the WADA prohibited list in 2009 as a class S4 hormone and metabolic modulator. The fact sheet records no confirmed hepatotoxicity data, so no liver rating can be assigned, and no half-life figure exists in the cited sources at all: the published detection data cover the sulfone metabolites, which remain in urine for up to about forty days after a single dose while the parent compound clears within roughly five days.
No human indication was ever approved, so the only figures available are user logs, and they are reported here as logs rather than as guidance. Those logs cluster at 10 mg per day for a first run and 10 to 20 mg per day for eight to twelve weeks, taken once a day, with 20 mg per day as the top of the range. Endurance and recomp contexts dominate, and the compound is discussed alongside the receptor modulators on the same shelf, such as Ostarine, Ligandrol and Testolone, or next to a fat-loss compound such as Clenbuterol. Nothing in those logs addresses the rodent carcinogenicity signal, and no source reviewed for this card suggests a safe human exposure level.
Each batch is produced under GMP conditions and checked by third-party HPLC, with a Certificate of Analysis held for the batch. Store away from light, excess heat and moisture.
For laboratory research only. Not for human consumption. Consult a qualified professional.
| Trade Name | Cardarine |
| Generic Name | GW-501516 |
| Manufacturer | Zyvex Pharmaceuticals |
| Dosage | 20 mg per tablet |
| Package | Sealed tablets |
| Half-Life | Not established in cited sources |
| Administration | Oral, once daily in community logs |
| Drug Class | PPAR-delta agonist, not a SARM |
| Detection | Sulfone metabolites up to about 40 days |
| Verification | Third-party HPLC per batch, COA on file |
| Shipping | International |
For laboratory research only. Not for human consumption. Consult a healthcare professional.
Before you ask
No. Cardarine is GW-501516, a PPAR-delta agonist, which means it acts on a nuclear receptor involved in fat metabolism rather than on the androgen receptor. The fact sheet states this explicitly, and the same caveat applies to the steroid label: it is not a steroid either, even though our shelf lists it with the receptor modulators.
The checked file records that development was discontinued in 2007 after carcinogenicity appeared in rodent studies at 3 mg per kg per day. That finding is the central safety fact about this molecule, and it is the reason no human therapeutic indication was ever approved. No source reviewed for this card proposes a human exposure level that avoids the concern.
The cited sources do not establish one, so the honest answer is that no half-life figure exists to quote. What the record does contain is detection data: sulfone metabolites can be found in urine for up to about forty days after a single dose, while the parent compound clears within roughly five days. A long metabolite tail is not the same thing as a long half-life.
User logs cluster at 10 mg per day for a first run and 10 to 20 mg per day for eight to twelve weeks, taken once a day, with 20 mg per day as the upper end of the range. These are logs, not clinical findings, and none of them addresses the rodent carcinogenicity signal. Nothing on this page is a dosing recommendation.
Yes. The fact sheet records that GW-501516 was added to the WADA prohibited list in 2009 as a class S4 hormone and metabolic modulator, and the long metabolite detection window is the practical consequence for anyone tested. The parent compound clears in about five days while the sulfone metabolites stay visible for weeks.
This offer is listed on GenXXLGear under Zyvex Pharmaceuticals with international shipping shown on the product page. Dispatch follows payment confirmation and the material is supplied strictly for laboratory research. Check the shipping group on the page for the option that applies to your location before ordering.
Be the first to share your experience with Zyvex Pharmaceuticals Cardarine GW-501516 20 mg Research Pack
Log in to write a reviewComplete the cycle
Out of stock
Out of stock
Out of stock